Release Date: 01-Sep-2014
“Global Intranasal Drug Delivery Market & Pipeline Insight” Report Highlights:
Intranasal drug delivery has evolved in the recent years as a significant method of delivering drugs through the nasal route. This method has been identified to have all the potential to achieve significant milestones in the pharmaceutical industry, as it is largely driven by its capability to cure local infections and chronic allergies. The human nose, which has a unique vascular structure, makes it specifically accessible for delivering small molecule drugs and biologics. By taking advantage of the conducive healthcare trends and changing demography, the intranasal drug delivery route is likely to capture the popularity of other leading methods of drug delivery such as oral and parenteral.
The global market for intranasal drug delivery was valued at approximately USD 15.4 billion in 2013. With factors such as ease of administration, potential to cure chronic diseases, rising ageing population working in full force, it is most likely that this market would register a CAGR of 5% to reach close to USD 21.7 billion by 2020.
The intranasal drug delivery market is likely to witness more developments in formulation techniques, like improvised micro-encapsulation techniques, more use of muco adhesive and surfactant agents and nanotechnology. This would in turn lead to an increased number of new chemical entities which could possibly be considered as the active ingredients for future intranasal drug products. Similarly, it is also expected that modern approaches to vaccination would be increasingly used which could also generate a wide range of new prophylactic and therapeutic products which would be appropriate for delivery through the nasal route.
For Report Sample Visit: Global Intranasal Drug Delivery Market & Pipeline Insight
Or Contact: avinash@kuickresearch.com